Clinical Trials in Miami

Showing 9421-9440 of 11,431 trials

Study of YM155 in Refractory Diffuse Large B-cell Lymphoma (DLBCL) Subjects

NCT00498914

A study in subjects with a type of B cell lymphoma (DLBCL)to evaluate the response rate, efficacy, safety and tolerability of YM155

Lymphoma, Large-Cell, DiffuseLymphoma, B-Cell Refractory

Astellas Pharma Inc41 participantsStarted Jun 2007

Beverly Hills, California, United States • Palo Alto, California, United States • Aurora, Colorado, United States +19 more locations

COMPLETEDPhase 1< 1 mile

Drug Interaction Study of Multiple Doses of Isavuconazole and a Single Dose of Bupropion

NCT01635972

The purpose of this study is to assess the effect of multiple doses of isavuconazole on the pharmacokinetics of a single dose of bupropion.

Pharmacokinetics of IsavuconazolePharmacokinetics of BupropionHealthy Volunteers

Astellas Pharma Global Development, Inc.24 participantsStarted Jun 2012

Miami, Florida, United States

COMPLETEDPhase 3< 1 mile

Study of the Efficacy and Safety of Alirocumab (REGN727/SAR236553) in Combination With Other Lipid-modifying Treatment (LMT) (ODYSSEY OPTIONS I)

NCT01730040

This is a randomized, double-blind, active-comparator, parallel-group study in patients at high cardiovascular risk with nonfamilial hypercholesterolemia or heterozygous familial hypercholesterolemia (heFH).

Hypercholesterolemia

Regeneron Pharmaceuticals355 participantsStarted Oct 2012

Mobile, Alabama, United States • Chandler, Arizona, United States • Tucson, Arizona, United States +94 more locations

Study of YM155 in Refractory Diffuse Large B-cell Lymphoma (DLBCL) Subjects

Drug Interaction Study of Multiple Doses of Isavuconazole and a Single Dose of Bupropion

Study of the Efficacy and Safety of Alirocumab (REGN727/SAR236553) in Combination With Other Lipid-modifying Treatment (LMT) (ODYSSEY OPTIONS I)

Find Trials by Condition in Miami

Effect of Febuxostat on Blood Pressure

Gadobutrol Enhanced MRA of the Renal Arteries

Safety, Efficacy and Pharmacokinetic Study of Dexmedetomidine in Pediatrics Ages ≥28 Weeks to ≤44 Weeks Gestational Age

Families Affected by Dementia: A Survey of Caregivers

An Open-Label Study to Evaluate Retreatment With LIPO-202

Long Term Study to Evaluate Safety and Efficacy of M518101 in Subjects With Plaque Psoriasis

A Study of Lumacaftor in Combination With Ivacaftor in Cystic Fibrosis Subjects Aged 12 Years and Older Who Are Homozygous for the F508del-CFTR Mutation

S0618 E7389 in Treating Patients With Metastatic or Recurrent Head and Neck Cancer

Sunitinib Malate in Treating Younger Patients With Recurrent, Refractory, or Progressive Malignant Glioma or Ependymoma

Study 767905/008 Extension Study: Alvimopan for Treatment of Opioid-Induced Bowel Dysfunction in Cancer Pain Subjects

A Study of Fresolimumab in Patients With Steroid-Resistant Primary Focal Segmental Glomerulosclerosis (FSGS)

A Study of Avastin (Bevacizumab) in Combination With Herceptin (Trastuzumab)/Docetaxel in Patients With HER2 Positive Metastatic Breast Cancer.

LCZ696 Compared to Valsartan in Patients With Chronic Heart Failure and Preserved Left-ventricular Ejection Fraction

Phase III Study in Refractory Behcet's Disease

Health Habits and Cancer Risk Comparison Among Migrant Sri Lankans and Sri Lankans

A Study to Evaluate the Safety and Efficacy of Adding Enfuvirtide to Oral Highly Active Antiretroviral Therapy (HAART) in Human Immunodeficiency Virus (HIV) Patients With Prior Treatment Experience

Induction-maintenance of Lopinavir/r in HIV-infected Subjects